Lateral Capital Management

Vaporox, Inc. specializes in developing a therapeutic delivery system aimed at treating various skin wounds. The company's core offering, Vaporous Hyperoxia Therapy (VHT), utilizes low-frequency ultrasonic waves to create anti-microbial particles that are delivered non-contact and non-thermally to the wound bed. This innovative approach is designed to address a range of conditions, including diabetic foot ulcers, burns, frostbite, gangrene, pressure ulcers, and skin grafts. Founded in 2016 and headquartered in Denver, Colorado, Vaporox aims to establish VHT as the preferred treatment for diabetic foot ulcers while exploring opportunities to extend its technology to other skin ailments or license it to medical device companies. The company was previously known as Wound Care, Inc. before rebranding in January 2019.

Agribody Technologies is a agricultural biotechnology company with patented technology that pinpoints and knocks down the gene that causes quick decay in perishable crops, resulting in 3X - 4X longer shelf life, more tolerance to stress, and up to 40% higher yields. CRISPR genome editing is the technical breakthrough enabling our precise novel plant trait development at low cost and high scalability, providing solutions for agricultural crop loss and food waste. We license and co-develop our technology.